Rebranding critical illness insurance as insured medical conditions to better reflect its coverage

Critical illness insurance has evolved far beyond its original scope but retains a misleading name. Experts argue that renaming it ‘insured medical conditions’ could improve consumer understanding and competition among insurers, reflecting the product’s true purpose of providing financial buffer during serious health events.

Critical illness insurance may be a familiar label, but the case for calling it something else is stronger than ever. What began in the 1980s as a narrow policy for a handful of serious diagnoses has grown into a much broader form of protection, covering dozens of medical events, diseases and procedures. In that sense, the industry’s current branding now undersells what the product actually does: it pays a set cash amount when someone is diagnosed with a covered condition, giving households a financial buffer at exactly the moment health and income may both be under pressure.

The story starts with Dr Christiaan Barnard’s landmark heart transplant on 3 December 1967, carried out at Groote Schuur Hospital in Cape Town. Guinness World Records says the recipient, Louis Washkansky, lived for 18 days after the operation, while medical histories and later tributes have noted the wider significance of the surgery in transforming cardiac care. The insurance idea that followed came from Barnard’s younger brother, Dr Marius Barnard, who argued that patients could survive medically yet still be ruined financially. That insight helped shape the first version of the product in 1983, then sold as “dread disease” cover.

Since then, the policy has moved far beyond its original four conditions. Canadian insurers have expanded lists of covered ailments and events over time, with some plans now including more than 30 triggers when partial and advance benefits are counted. That broader menu has brought in cover for cancers, strokes, organ transplants, neurological diseases, loss of sight or hearing, and even certain surgeries. In practical terms, it means the product is no longer just about one catastrophic diagnosis; it is closer to a payment triggered by a serious medical setback that can disrupt a family’s finances, whether through time off work, travel for treatment, home care or extra bills.

That is why the terminology now looks dated. “Critical” is a slippery word, and it can sound more like a judgement than a description. It also fails to capture the range of claims the policy actually pays. A heart attack is an event, not a disease. Surgery is a procedure. Paralysis is a functional loss. Cancer may be an abnormal growth rather than an “illness” in the everyday sense. According to the article’s argument, the label creates confusion at precisely the point where clarity matters most: when consumers are comparing policies and trying to understand what is, and is not, covered.

A more useful name, the article argues, would be “insured medical conditions”. That may sound less dramatic, but it is more precise and less loaded. It would also make it easier for insurers to compete on the breadth and detail of their coverage rather than on a vague umbrella term. For buyers, that could be helpful, because the real difference between policies is often not the headline name but the fine print: which conditions are covered, how definitions are written, whether partial payouts are available and how much protection can be bought. As Dr Barnard’s legacy shows, the point was never branding for its own sake. It was making sure a serious health event does not become a financial one as well.